• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Catalog Number 1011534-18
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/19/2022
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a de novo lesion located in the renal artery that was moderately calcified, mildly tortuous and 80% stenosed.After advancing the 6x18mm herculink elite stent delivery system to the lesion, the stent could not be seen under fluoroscopy, so the delivery system was removed from patient.There was no reported adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Subsequent to the previously filed report, additional information was received: the stent was able to be seen under fluoroscopy during advancement to the lesion but with less radiopacity once in the renal artery.No additional information was provided.
 
Manufacturer Narrative
A visual inspection was performed on the returned device.The reported difficult or delayed positioning (poor visibility) was not confirmed, as the balloon markers were visible under fluoroscopy with no anomalies noted.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.The investigation was unable to determine a conclusive cause for the reported difficult or delayed positioning (poor visibility).There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14847743
MDR Text Key295797871
Report Number2024168-2022-06993
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011534-18
Device Lot Number2022261
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/06/2022
Initial Date FDA Received06/28/2022
Supplement Dates Manufacturer Received09/07/2022
Supplement Dates FDA Received09/12/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-